Inogen, Inc. (NASDAQ:INGN) Rating Changes as of May 3, 2018

May 3, 2018 - By Ira Colvard

Inogen, Inc. (NASDAQ:INGN) Corporate Logo
Big Money Sentiment decreased to 1.18 in Q4 2017. It has change of 0.02, from 2017Q3’s 1.2. The ratio is negative due to Inogen, Inc. positioning: 19 sold and 68 reduced. 37 funds acquired positions and 66 increased positions. Investors holded 20.61 million in 2017Q3 but now own 20.27 million shares or 1.65% less.
Sei Investments owns 2,780 shs. Aqr Capital Mngmt Limited Liability reported 0% stake. Dorsey & Whitney Tru Co Ltd Liability Corporation holds 0.04% or 2,029 shs in its capital. Suntrust Banks Inc stated it has 0% in Inogen, Inc. (NASDAQ:INGN). C M Bidwell & Associate Limited stated it has 2,410 shs. Laurion Ltd Partnership has 6,900 shs for 0% of their capital. 5,525 are owned by Metropolitan Life Ins Ny. Wells Fargo & Mn owns 276,031 shs for 0.01% of their capital. Alliancebernstein Lp has invested 0% in Inogen, Inc. (NASDAQ:INGN). Jpmorgan Chase holds 0% of its capital in Inogen, Inc. (NASDAQ:INGN) for 53,102 shs. Geode Cap Ltd Liability Corporation holds 0.01% or 155,022 shs in its capital. Mason Street, Wisconsin-based fund reported 4,451 shs. Blackrock, New York-based fund reported 2.31M shs. Tirschwell Loewy Incorporated reported 164,055 shs stake. 36,350 were reported by Smith Asset Management Group Inc Lp.

Inogen, Inc. (NASDAQ:INGN) Ratings Coverage

Total analysts of 6 have positions in Inogen (NASDAQ:INGN) as follows: 6 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since November 8, 2017 according to StockzIntelligence Inc Inogen has 9 analyst reports. On Tuesday, May 1 J.P. Morgan maintained the shares of INGN in report with “Buy” rating. On Wednesday, November 8 the company was maintained by Needham. On Friday, April 13 the rating was maintained by Needham with “Buy”. In Tuesday, May 1 report JP Morgan maintained the stock with “Overweight” rating. On Tuesday, February 20 the stock has “Overweight” rating by PiperJaffray. On Tuesday, May 1 Needham maintained Inogen, Inc. (NASDAQ:INGN) rating. Needham has “Buy” rating and $21500 target. On Wednesday, November 8 Leerink Swann maintained Inogen, Inc. (NASDAQ:INGN) rating. Leerink Swann has “Buy” rating and $120.0 target. The stock rating was maintained by Needham with “Buy” on Wednesday, February 28. On Tuesday, February 20 the firm has “Buy” rating by Piper Jaffray given. Listed here are Inogen, Inc. (NASDAQ:INGN) PTs and latest ratings.

01/05/2018 Broker: J.P. Morgan Rating: Buy New Target: $180.0000 Maintain
01/05/2018 Broker: Needham Rating: Buy New Target: $215.0000 Maintain
01/05/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Overweight Old Target: $150 New Target: $180 Maintain
13/04/2018 Broker: Needham Rating: Buy New Target: $150.0000 Maintain
28/02/2018 Broker: Needham Rating: Buy New Target: $150.0 Maintain
20/02/2018 Broker: PiperJaffray Old Rating: Neutral New Rating: Overweight Upgrade
20/02/2018 Broker: Piper Jaffray Rating: Buy Upgrade
08/11/2017 Broker: Leerink Swann Rating: Buy New Target: $120.0 Maintain
08/11/2017 Broker: Needham Rating: Buy New Target: $125.0 Maintain

The stock decreased 0.24% or $0.3955 during the last trading session, touching $163.0645.Currently Inogen, Inc. is uptrending after 59.63% change in last May 3, 2017. INGN has also 137,877 shares volume. INGN outperformed the S&P500 by 48.08%.

Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally.The company has $3.46 billion market cap. The companyÂ’s oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.The P/E ratio is 169.86. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.

Inogen, Inc. (NASDAQ:INGN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: